Momenta Pharma announces closing of $230 million public offering of common stock
Momenta Pharmaceuticals announced the closing of its underwritten public offering of 20,000,000 shares of its common stock at the public offering price of $11.50 per share, which includes the exercise in full of the underwriter’s option to purchase additional shares of common stock. December 11, 2018